London; United Kingdom/Madrid; SPAIN
Aglaris is developing an automated cell culture bioreactor for the mass production of human stem cells.
Aglaris Cell stems from the collaboration between researchers at two institutions, the biomaterials group at Barcelona’s IQS and the group for the Regulation of the Genetic Expression and Stability of Stem Cells at a leading organization.
BioMediTech, a joint institute of Tampere University of Technology and University of Tampere, brings together a powerful mix of multidisciplinary expertise in life sciences and medical technology. Over 250 scientists conduct research and education in the fields of cell and molecular biology, genetics, biomaterials, biosensors, computational systems, biotechnology, biomedical engineering, and regenerative medicine. The institute aims not only to integrate and strengthen the local tradition of excellence in basic life-science research and teaching, but also to create new platforms for discovery and innovation.
Bioversys AG is a privately held Swiss biopharmaceutical company located in Basel that focuses on research and development of new drugs and compounds, which switch-off drug resistance within bacterial pathogens and restore the efficacy of approved antibiotics. Spun out of the ETH-Zurich in 2008, the company has profound technological expertise that is based on solid IP.
Campania Bioscience Scarl
Campania Bioscience is a regional cluster set in Naples (Campania region – Southern Italy) gathering together competences and facilities in the fields of Health, Biotech and Agro-food, with the aim of valorising partners’ expertise in the value chain, stimulating exploitation of cluster assets, supporting knowledge transfer and encouraging international networking and partnerships.
Centre for Integrative Biology, CIBIO, University of Trento
The Centre for Integrative Biology (CIBIO) provides a range of cell biology, genomics, and informatics research resources and services to the University of Trento community as well as to investigators outside of the university.
CIBIO is a hub for classical and molecular biology. It strives to create a suitable environment for merging classical cellular and molecular biology approaches. The center is committed to multi-disciplinary research projects involving both internal initiatives and multi-institutional collaborations.
Fundación MEDINA is a non-profit research organisation with focus on drug discovery. The screening of microbial natural products will contribute to the discovery of new drugs that could meet current therapeutic needs.
Information Processing Laboratory (IPL), Department of Electrical and Computer Engineering, University of Thessaloniki
The IPL delivers basic and industry research, plus technology transfer in databases and knowledge discovery, intelligent agents, software engineering, bioinformatics, biomedical signal and image processing, enviromatics, semantic web, multiple cue human-computer interactions and computer vision.
IPL is highly active in the intelligent systems field, with specialisms including bioinformatics and their deployment on large scale computational infrastructures (such as the European Grid Infrastructure).
IPL recently implemented a quality management system in conformance with ISO 9001:2008.
IRBM Science Park
Pomezia (RM); Italy
IRBM Science Park started in October 2009 as a spin- off of Istituto di Ricerche di Biologia Molecolare P. Angeletti S.p.a., the Italian research site of Merck Research Laboratories.
IRBM Science Park provides a broad spectrum of research services for Drug Discovery, Organic Chemistry, Biomedical Sciences and Biotechnology Applications, backed by decades of industry experience. The Institute has expertise with small molecules, peptides, and biologics.
Leitat - Technological Center
LEITAT is a Technological Center, member of TECNIO and recognized by the Ministry of Economy and Competitiveness, that aims to collaborate with companies and institutions by adding technological value both to products and processes, and focuses its activity on research, development and industrial innovation (R+D+2i).
OnTarget Chemistry – was established, initially as OncoTargeting, in 2008 as a spin-out from the medicinal chemistry, combinatorial chemistry and preclinical analysis departments of Pharmacia (Biovitrum). We have continued to employ some of the industry’s most experienced chemists and run a well-trimmed organization with solid values of service, quality and efficiency.
Our repertoire includes a complete medicinal chemistry offering. We run all the usual synthesis and analysis services alongside more rare and demanding specialities. We are located in the former Pharmacia properties of Uppsala Business Park, Sweden with purpose-built premises and well-equipped labs.
ProtATonce provides A-to-Z support in the analysis and generation of multi-omics data for drug and biomarker discovery. Our state-of-the-art facilities for tissue culture and molecular biology, the unique expertise in multiplexed proteomic and phosphoproteomic assays (Luminex assays), our advanced computational tools, and our happy customers guarantee a unique high quality service.
Liverpool, United Kingdom
Redx Pharma has quickly established itself as one of the largest biotechnology companies in Europe, focused on the development of a wide range of early stage, proprietary small molecule therapeutics to address high unmet medical needs in cancer and infectious disease.
University of Birmingham
Birmingham; United Kingdom
Birmingham is constantly developing and evolving in its desire to become a leading global university. This is being achieved through the enhanced research power and reach; the distinctiveness of exceptional student experience; the breadth and depth of academic portfolio; size and extent of the global networks.
The School of Biosciences has achieved an impressive performance in the Research Excellence Framework 2014 (REF 2014) rising up to 6th place in the Russell Group. This strong performance has been achieved through focusing on research strengths across the School, and by the recruitment of many new staff, including seven Birmingham Fellows, who have all made a big contribution to the School’s research.